$13.99
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026
Wall Street Analysts See a 230.23% Upside in Promis Neurosciences (PMN): Can the Stock Really Move This High?
Cantor Fitzgerald Initiates ProMIS Neurosciences at Overweight
Overview
52-week range
$6.27
$40
23% of range
Avg surprise (last 1)
-31.8%
Avg reaction (last 2)
-0.9%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-1.26 | — | — | -500.0% | -1.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.24 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.29 | $-0.22 | -31.8% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.21 | — | — | — | 0.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.31 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.13 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.19 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.19 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.27 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$1.45 | -$7.25 | +80.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-9M | — | $-12M | $-10M | $-7M | — | $-4M | $-3M |
| Net income | $-8M | — | $-12M | $-10M | $-7M | — | $9M | $-3M |
| EPS (diluted) | $-1.26 | — | $-0.24 | $-0.29 | $-5.27 | — | $0.31 | $-0.13 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $64M | $6M | $15M | $5M | $8M | $13M | $22M | $992,463 |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $66M | $9M | $21M | $10M | $14M | $19M | $25M | $1M |
| Total assets | $67M | $9M | $21M | $10M | $14M | $19M | $25M | $1M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $7M | $10M | $12M | $10M | $4M | $2M | $17M | $4M |
| Total equity | $61M | $-1M | $9M | $-382,579 | $9M | $16M | $7M | $-2M |
Implied volatility — last 90 days
No IV snapshots yet for PMN.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.